New MspI polymorphism at +83 bp of the human apolipoprotein Al gene: Association with increased circulating high density lipoprotein cholesterol levels

Genetic Epidemiology

Volumn 13, Issue 1, 1996, Pages 1-10

  Wang, X L ^a   Badenhop, R ^a   Humphrey, K E ^b   Wilcken, D E L ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c PRINCE HENRY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BASE PAIRING; CHILD; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; APOLIPOPROTEIN A-I; BASE SEQUENCE; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL, HDL; DEOXYRIBONUCLEASE HPAII; DNA; FEMALE; GENE FREQUENCY; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEW SOUTH WALES; POLYMORPHISM, GENETIC; SEX DISTRIBUTION;

EID: 0029995227     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(1996)13:1<1::AID-GEPI1>3.0.CO;2-D     Document Type: Article

References (25)

1. Assmann G, von Eckardstein A, Funke H (1993): High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations (review). Circulation 87(Suppl III):III28-34.
2. Badimon JJ, Fuster V, Badimon L (1992): Role of high density lipoproteins in the regression of atherosclerosis. Circulation 86(Suppl III):III86-94.
3. Barter PJ (1990): The role of HDL in reverse cholesterol transport and atherosclerosis. Lipid Rev 4:89-94.
4. Blangero J, Williams-Blangero S, Mahaney MC (1993): Multivariate genetic analysis of apo AI concentration and HDL subfractions: Evidence for major locus pleiotropy, Genet Epidemiol 10:617-622.
5. Falcone D, Andrews DW (1991): Both the 5′ untranslated region and the sequences surrounding the start site contribute to efficient initiation of translation in vitro. Mol Cell Biol 11:2656-2664.
6. Frick M, Elo O, Happa K, Heinonen OP. Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Keskinen P, Manninen V (1987): Helsinki Heart Study primary prevention trial with genfibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317-1237-1245.
7. Humphries S, Paul H, Jeenah M, Rosseneu M, Miller N (1990): The contribution of variation at the apo AI-CIII-AIV gene locus to the determination of HDL-cholesterol and apo AI levels. In Carlson LA (ed): "Disorders of HDL." London: Smith-Gordon, pp 63-70.
8. Kozak M (1991): Structural features in eukaryotic mRNAs that modulate the initiation of translation (minireview). J Biol Chem 266:19867-19870.
9. Kozak M (1994): Features in the 5′ non-coding sequences of rabitt a and β-globin mRNAs that affect translation efficiency. J Mol Biol 235:95-110.
10. Lewin B (1990): Control of RNA processing. In Lewin B (ed): "Genes IV." Oxford: Oxford University Press, Cell Press, pp 610-621.
11. Miller SA, Dykes DD, Polesky HF (1988): A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
12. Pagani F, Giudici GA, Baralle FE, Vergani C (1992): Association of a polymorphism in the apo AI gene promoter with hyperalphalipoproteinemia. Eur J Epidemiol 8(Suppl 1):54-58.
13. Papazafiri P, Ogami K, Ramji DP, et al. (1991): Promoter elements and factors involved in hepatic transcription of the human apo AI gene positive and negative regulators bind to overlapping sites. J Biol Chem 266:5790-5797.
14. Paul-Hayase H, Rosseneu M, Robinson D, Van Biervliet JP, Deslypere JP, Humphries SE (1992): Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet 88:439-446.
15. Shemer R, Walsh A, Eisenberg S, Breslow JL, Razin A (1990): Tissue-specific methylation patterns and expression of the human apolipoprotein AI gene. J Biol Chem 265:1010-1015.
16. Sonenberg N (1994): mRNA translation: influence of the 5′ and 3′ untranslated regions. Curr Opin Genet Dev 4:310-315.
17. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH (1991): A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325:373-381.
18. Steinmetz J, Boerwinkle E, Gueguen R, Visvikis S, Henny J, Siest G (1992): Multivariate genetic analysis of high density lipoprotein. Atherosclerosis 92:219-227.
19. Talmud PJ, Ye S, Humphries SE, EARS Group (1994): Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study. Genet Epidemiol 11:265-280.
20. Tribble DL, Krauss RM (1993): HDL and coronary artery disease (review). Adv Intern Med 38:1-29.
21. Tuteja R, Tuteja N, Melo C, Casari G, Baralle FE (1992): Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition. FEBS Lett 304:98-101.
22. Wang XL, Tam C, McCredie RM, Wilcken DEL (1994): Determinants of severity of coronary artery disease in Australian men and women. Circulation 89:1974-1981.
23. Wang XL, Badenhop R, Humphrey K, Wilcken DEL (1995): C to T and G to A transitions are responsible for loss of a MspI restriction site in the 5′-region of the human apolipoprotein AI gene. Hum Genet 95:473-475.
24. Wilcken DEL, Wang XL, Greenwood J, Lynch J (1993): Lipoprotein(a) and apolipoproteins B and A-I in children and coronary vascular events in their grandparents. J Pediatr 123:519-526.
25. Xu C-F, Nanjee MN, Savill J, et al. (1990): Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children. Am J Hum Genet 47:429-439.